| Moderna (MRNA) |
United States |
$173.588B |
53.62 |
| Bristol Myers Squibb (BMY) |
United States |
$136.238B |
9.07 |
| Amgen (AMGN) |
United States |
$124.575B |
13.49 |
| CSL (CSLLY) |
Australia |
$102.379B |
0.00 |
| Gilead Sciences (GILD) |
United States |
$89.785B |
8.68 |
| BioNTech SE (BNTX) |
Germany |
$87.107B |
18.80 |
| Regeneron Pharmaceuticals (REGN) |
United States |
$69.722B |
11.97 |
| Illumina (ILMN) |
United States |
$65.576B |
74.50 |
| Vertex Pharmaceuticals (VRTX) |
United States |
$48.850B |
18.98 |
| Biogen (BIIB) |
United States |
$44.738B |
12.28 |
| BeiGene (BGNE) |
Cayman Islands |
$37.507B |
0.00 |
| Seagen (SGEN) |
United States |
$28.420B |
47.92 |
| Genmab (GMAB) |
Denmark |
$28.322B |
69.55 |
| Genmab (GNMSF) |
Denmark |
$27.553B |
68.87 |
| Horizon Therapeutics Public (HZNP) |
Ireland |
$24.783B |
23.49 |
| Bio-Rad Laboratories (BIO.B) |
United States |
$23.483B |
50.05 |
| Alnylam Pharmaceuticals (ALNY) |
United States |
$22.621B |
0.00 |
| Bio-Techne Corp (TECH) |
United States |
$20.882B |
93.91 |
| Exact Sciences (EXAS) |
United States |
$18.596B |
0.00 |
| Novavax (NVAX) |
United States |
$17.693B |
0.00 |
| ARGENX SE-ADR (ARGX) |
Netherlands |
$17.061B |
0.00 |
| Repligen (RGEN) |
United States |
$16.850B |
128.41 |
| Incyte (INCY) |
United States |
$16.781B |
39.78 |
| BioMarin Pharmaceutical (BMRN) |
United States |
$14.257B |
102.32 |
| Guardant Health (GH) |
United States |
$13.376B |
0.00 |
| QIAGEN (QGEN) |
Netherlands |
$12.389B |
20.98 |
| Intellia Therapeutics (NTLA) |
United States |
$11.559B |
0.00 |
| CureVac (CVAC) |
Germany |
$10.301B |
0.00 |
| CRISPR Therapeutics AG (CRSP) |
Switzerland |
$9.489B |
24.37 |
| Ascendis Pharma (ASND) |
Denmark |
$9.109B |
0.00 |
| Mirati Therapeutics (MRTX) |
United States |
$8.985B |
0.00 |
| Biohaven Pharmaceutical Holding (BHVN) |
United States |
$8.829B |
0.00 |
| SWEDISH ORP BIO (BIOVF) |
Sweden |
$8.417B |
30.17 |
| Acceleron Pharma (XLRN) |
United States |
$8.380B |
0.00 |
| Vir Biotechnology (VIR) |
United States |
$7.124B |
0.00 |
| Sarepta Therapeutics (SRPT) |
United States |
$6.897B |
0.00 |
| Beam Therapeutics (BEAM) |
United States |
$6.828B |
0.00 |
| Fate Therapeutics (FATE) |
United States |
$6.815B |
0.00 |
| Ultragenyx Pharmaceutical (RARE) |
United States |
$6.666B |
0.00 |
| Exelixis (EXEL) |
United States |
$6.528B |
71.45 |
| Denali Therapeutics (DNLI) |
United States |
$6.426B |
182.17 |
| Legend Biotech (LEGN) |
United States |
$6.343B |
0.00 |
| Blueprint Medicines (BPMC) |
United States |
$6.209B |
17.52 |
| Twist Bioscience (TWST) |
United States |
$6.001B |
0.00 |
| Halozyme Therapeutics (HALO) |
United States |
$5.984B |
24.44 |
| NeoGenomics (NEO) |
United States |
$5.942B |
805.33 |
| I-Mab (IMAB) |
China |
$5.838B |
0.00 |
| AbCellera Biologics (ABCL) |
|
$5.674B |
0.00 |
| Adaptive Biotechnologies (ADPT) |
United States |
$5.595B |
0.00 |
| Certara (CERT) |
United States |
$5.464B |
0.00 |
| Alkermes (ALKS) |
Ireland |
$4.858B |
143.38 |
| Arvinas (ARVN) |
United States |
$4.746B |
0.00 |
| Editas Medicine (EDIT) |
United States |
$4.314B |
0.00 |
| Reata Pharmaceuticals (RETA) |
United States |
$4.000B |
0.00 |
| Arena Pharmaceuticals (ARNA) |
United States |
$3.729B |
0.00 |
| SpringWorks Therapeutics (SWTX) |
United States |
$3.675B |
0.00 |
| Galapagos (GLPG) |
Belgium |
$3.646B |
0.00 |
| BAVARIAN NORDIC (BVNRY) |
Denmark |
$3.484B |
0.00 |
| Prothena (PRTA) |
Ireland |
$3.405B |
0.00 |
| Kymera Therapeutics (KYMR) |
United States |
$3.213B |
0.00 |
| ALX Oncology Holdings (ALXO) |
United States |
$3.139B |
0.00 |
| Insmed (INSM) |
United States |
$3.086B |
0.00 |
| Emergent Biosolutions (EBS) |
United States |
$3.068B |
7.40 |
| Apellis Pharmaceuticals (APLS) |
United States |
$2.976B |
0.00 |
| Amicus Therapeutics (FOLD) |
United States |
$2.932B |
0.00 |
| Cytokinetics (CYTK) |
United States |
$2.830B |
0.00 |
| Intra-Cellular Therapies (ITCI) |
United States |
$2.795B |
0.00 |
| Heska (HSKA) |
United States |
$2.777B |
532.37 |
| ACADIA Pharmaceuticals (ACAD) |
United States |
$2.683B |
0.00 |
| Myriad Genetics (MYGN) |
United States |
$2.632B |
0.00 |
| Arcus Biosciences (RCUS) |
United States |
$2.598B |
0.00 |
| Instil Bio (TIL) |
United States |
$2.544B |
0.00 |
| Celldex Therapeutics (CLDX) |
United States |
$2.528B |
0.00 |
| Morphic Holding (MORF) |
United States |
$2.460B |
0.00 |
| Sorrento Therapeutics (SRNE) |
United States |
$2.459B |
0.00 |
| C4 Therapeutics (CCCC) |
United States |
$2.420B |
0.00 |
| Ligand Pharmaceuticals (LGND) |
United States |
$2.414B |
35.30 |
| Vericel (VCEL) |
United States |
$2.410B |
287.17 |
| Seer (SEER) |
|
$2.288B |
0.00 |
| Atea Pharmaceuticals (AVIR) |
United States |
$2.171B |
0.00 |
| Alector (ALEC) |
United States |
$2.168B |
0.00 |
| Myovant Sciences (MYOV) |
United Kingdom |
$2.102B |
0.00 |
| Harmony Biosciences Holdings (HRMY) |
United States |
$2.097B |
35.72 |
| Amarin (AMRN) |
Ireland |
$2.036B |
515.00 |
| Revance Therapeutics (RVNC) |
United States |
$2.000B |
0.00 |
| ADC Therapeutics SA (ADCT) |
Switzerland |
$1.988B |
0.00 |
| Castle Biosciences (CSTL) |
United States |
$1.946B |
0.00 |
| REGENXBIO (RGNX) |
United States |
$1.919B |
0.00 |
| Deciphera Pharmaceuticals (DCPH) |
United States |
$1.914B |
0.00 |
| Berkeley Lights (BLI) |
United States |
$1.819B |
0.00 |
| NGM Biopharmaceuticals (NGM) |
United States |
$1.781B |
0.00 |
| Global Blood Therapeutics (GBT) |
United States |
$1.749B |
0.00 |
| Inovio Pharmaceuticals (INO) |
United States |
$1.712B |
0.00 |
| Dynavax Technologies (DVAX) |
United States |
$1.709B |
0.00 |
| PHARMA MAR SA (PHMMF) |
Spain |
$1.699B |
0.00 |
| UniQure (QURE) |
Netherlands |
$1.696B |
5.77 |
| Dicerna Pharmaceuticals (DRNA) |
United States |
$1.680B |
0.00 |
| Zymeworks (ZYME) |
Canada |
$1.654B |
0.00 |
| Codexis (CDXS) |
United States |
$1.654B |
0.00 |
| MorphoSys AG (MOR) |
Germany |
$1.643B |
0.00 |
| Nurix Therapeutics (NRIX) |
United States |
$1.599B |
0.00 |
| Ocugen (OCGN) |
United States |
$1.576B |
0.00 |
| Bionano Genomics (BNGO) |
United States |
$1.552B |
0.00 |
| OXFORD BIOMEDCL (OXBDF) |
United Kingdom |
$1.536B |
0.00 |
| Kadmon Holdings (KDMN) |
United States |
$1.505B |
0.00 |
| Immunocore Holdings (IMCR) |
United Kingdom |
$1.478B |
0.00 |
| Genetron Holdings (GTH) |
China |
$1.463B |
0.00 |
| MaxCyte (MXCT) |
United States |
$1.442B |
0.00 |
| Arcturus Therapeutics Holdings (ARCT) |
United States |
$1.434B |
0.00 |
| PureTech Health (PRTC) |
United States |
$1.413B |
0.00 |
| Y-mAbs Therapeutics (YMAB) |
United States |
$1.408B |
0.00 |
| Inhibrx (INBX) |
United States |
$1.403B |
0.00 |
| Scholar Rock Holding (SRRK) |
United States |
$1.396B |
0.00 |
| Sangamo Therapeutics (SGMO) |
United States |
$1.388B |
0.00 |
| Zealand Pharma (ZEAL) |
Denmark |
$1.381B |
0.00 |
| Travere Therapeutics (TVTX) |
United States |
$1.367B |
0.00 |
| Agenus (AGEN) |
United States |
$1.359B |
0.00 |
| Coherus BioSciences (CHRS) |
United States |
$1.343B |
0.00 |
| Avid Bioservices (CDMO) |
United States |
$1.287B |
262.25 |
| Fulcrum Therapeutics (FULC) |
United States |
$1.242B |
0.00 |
| Bluebird Bio (BLUE) |
United States |
$1.238B |
0.00 |
| Repare Therapeutics (RPTX) |
Canada |
$1.169B |
0.00 |
| BioAtla (BCAB) |
United States |
$1.168B |
0.00 |
| RAPT THERAPTICS (RAPT) |
United States |
$1.164B |
0.00 |
| Precigen (PGEN) |
United States |
$1.132B |
0.00 |
| MannKind (MNKD) |
United States |
$1.131B |
0.00 |
| Northwest Biotherapeutics (NWBO) |
United States |
$1.129B |
0.00 |
| Forma Therapeutics Holdings (FMTX) |
United States |
$1.124B |
0.00 |
| Bicycle Therapeutics (BCYC) |
United Kingdom |
$1.114B |
0.00 |
| ImmunityBio (IBRX) |
United States |
$1.113B |
0.00 |
| Absci (ABSI) |
United States |
$1.108B |
0.00 |
| IDEAYA Biosciences (IDYA) |
United States |
$1.032B |
0.00 |
| Nkarta (NKTX) |
United States |
$1.030B |
0.00 |
| Prometheus Biosciences (RXDX) |
United States |
$1.016B |
0.00 |
| Zealand Pharma (ZLDPF) |
Denmark |
$0.997B |
0.00 |
| Merus (MRUS) |
Netherlands |
$0.986B |
0.00 |
| Syndax Pharmaceuticals (SNDX) |
United States |
$0.963B |
0.00 |
| Vanda Pharmaceuticals (VNDA) |
United States |
$0.943B |
29.22 |
| Immatics (IMTX) |
Germany |
$0.921B |
0.00 |
| Sutro Biopharma (STRO) |
United States |
$0.908B |
0.00 |
| Avidity Biosciences (RNA) |
United States |
$0.903B |
0.00 |
| BeyondSpring (BYSI) |
United States |
$0.896B |
0.00 |
| VBI Vaccines (VBIV) |
United States |
$0.847B |
0.00 |
| Adaptimmune Therapeutics (ADAP) |
United Kingdom |
$0.843B |
0.00 |
| Protagonist Therapeutics (PTGX) |
United States |
$0.834B |
0.00 |
| Mesoblast (MESO) |
Australia |
$0.800B |
0.00 |
| Shattuck Labs (STTK) |
United States |
$0.799B |
0.00 |
| Akoya Biosciences (AKYA) |
United States |
$0.780B |
0.00 |
| Curis (CRIS) |
United States |
$0.777B |
0.00 |
| Precision BioSciences (DTIL) |
United States |
$0.766B |
0.00 |
| Cara Therapeutics (CARA) |
United States |
$0.764B |
95.31 |
| Amryt Pharma (AMYT) |
United Kingdom |
$0.760B |
0.00 |
| AnaptysBio (ANAB) |
United States |
$0.739B |
0.00 |
| Xenon Pharmaceuticals (XENE) |
Canada |
$0.734B |
0.00 |
| Keros Therapeutics (KROS) |
United States |
$0.717B |
0.00 |
| Mersana Therapeutics (MRSN) |
United States |
$0.710B |
0.00 |
| Lexicon Pharmaceuticals (LXRX) |
United States |
$0.702B |
12.79 |
| MiMedx (MDXG) |
United States |
$0.688B |
0.00 |
| Adagene (ADAG) |
China |
$0.663B |
0.00 |
| G1 THERAPEUTICS (GTHX) |
United States |
$0.659B |
0.00 |
| Acumen Pharmaceuticals (ABOS) |
United States |
$0.657B |
0.00 |
| Cellectis S.A (CLLS) |
France |
$0.656B |
0.00 |
| Pliant Therapeutics (PLRX) |
United States |
$0.656B |
0.00 |
| Seres Therapeutics (MCRB) |
United States |
$0.653B |
0.00 |
| Sinovac Biotech (SVA) |
China |
$0.642B |
6.47 |
| Innate Pharma S.A (IPHA) |
France |
$0.641B |
0.00 |
| Affimed (AFMD) |
Germany |
$0.628B |
0.00 |
| Pharming Group (PHAR) |
Netherlands |
$0.627B |
0.00 |
| Spero Therapeutics (SPRO) |
United States |
$0.616B |
0.00 |
| Pharming Group (PHGUF) |
Netherlands |
$0.612B |
24.44 |
| MeiraGTx Holdings (MGTX) |
United States |
$0.599B |
0.00 |
| ALBIREO PHARMA (ALBO) |
United States |
$0.593B |
0.00 |
| Epizyme (EPZM) |
United States |
$0.586B |
0.00 |
| Ambrx Biopharma (AMAM) |
United States |
$0.580B |
0.00 |
| VistaGen Therapeutics (VTGN) |
United States |
$0.575B |
0.00 |
| Clovis Oncology (CLVS) |
United States |
$0.573B |
0.00 |
| Anika Therapeutics (ANIK) |
United States |
$0.572B |
0.00 |
| Nabriva Therapeutics AG (NBRV) |
Ireland |
$0.572B |
0.00 |
| Bolt Biotherapeutics (BOLT) |
United States |
$0.569B |
0.00 |
| Gritstone Bio (GRTS) |
United States |
$0.569B |
0.00 |
| DBV Technologies S.A (DBVT) |
France |
$0.562B |
0.00 |
| Vaccitech (VACC) |
United Kingdom |
$0.549B |
0.00 |
| Inventiva S.A (IVA) |
France |
$0.537B |
0.00 |
| Intercept Pharmaceuticals (ICPT) |
United States |
$0.529B |
0.00 |
| Selecta Biosciences (SELB) |
United States |
$0.512B |
0.00 |
| AC Immune SA (ACIU) |
Switzerland |
$0.508B |
0.00 |
| Verastem (VSTM) |
United States |
$0.499B |
0.00 |
| Clene (CLNN) |
United States |
$0.495B |
0.00 |
| Basilea Pharmaceutica AG (BPMUF) |
Switzerland |
$0.494B |
0.00 |
| XBiotech (XBIT) |
United States |
$0.488B |
0.00 |
| Autolus Therapeutics (AUTL) |
United Kingdom |
$0.487B |
0.00 |
| Bellus Health (BLU) |
Canada |
$0.472B |
0.00 |
| ChromaDex (CDXC) |
United States |
$0.462B |
0.00 |
| Compugen (CGEN) |
Israel |
$0.459B |
0.00 |
| Geron (GERN) |
United States |
$0.452B |
0.00 |
| Arbutus Biopharma (ABUS) |
United States |
$0.431B |
0.00 |
| Codiak BioSciences (CDAK) |
United States |
$0.427B |
0.00 |
| ProQR Therapeutics (PRQR) |
Netherlands |
$0.425B |
0.00 |
| Oncobiologics (OTLK) |
United States |
$0.423B |
0.00 |
| Starpharma Holdings (SPHRY) |
Australia |
$0.412B |
0.00 |
| Cue Biopharma (CUE) |
United States |
$0.407B |
0.00 |
| SQZ Biotechnologies (SQZ) |
United States |
$0.406B |
0.00 |
| KaloBios Pharmaceuticals (HGEN) |
United States |
$0.406B |
0.00 |
| Clearside Biomedical (CLSD) |
United States |
$0.403B |
0.00 |
| BioDelivery Sciences (BDSI) |
United States |
$0.393B |
12.09 |
| ZIOPHARM Oncology Inc (ZIOP) |
United States |
$0.392B |
0.00 |
| Pieris Pharmaceuticals (PIRS) |
United States |
$0.390B |
0.00 |
| Athenex (ATNX) |
United States |
$0.383B |
0.00 |
| ANI Pharmaceuticals (ANIP) |
United States |
$0.369B |
10.07 |
| Aeglea BioTherapeutics (AGLE) |
United States |
$0.367B |
0.00 |
| Cogent Biosciences (COGT) |
United States |
$0.358B |
0.00 |
| Orchard Therapeutics (ORTX) |
United Kingdom |
$0.354B |
0.00 |
| Neoleukin Therapeutics (NLTX) |
United States |
$0.350B |
0.00 |
| Theratechnologies (THTX) |
Canada |
$0.342B |
0.00 |
| CytomX Therapeutics (CTMX) |
United States |
$0.341B |
0.00 |
| Fortress Biotech (FBIO) |
United States |
$0.339B |
0.00 |
| Prima BioMed (IMMP) |
Australia |
$0.334B |
0.00 |
| Opthea (OPT) |
Australia |
$0.333B |
0.00 |
| Athersys (ATHX) |
United States |
$0.333B |
0.00 |
| INmune Bio (INMB) |
United States |
$0.327B |
0.00 |
| EYEPOINT PHARMACEUTICALS, INC (EYPT) |
United States |
$0.318B |
0.00 |
| Syros Pharmaceuticals (SYRS) |
United States |
$0.315B |
0.00 |
| Angion Biomedica (ANGN) |
United States |
$0.313B |
0.00 |
| AquaBounty Technologies (AQB) |
United States |
$0.313B |
0.00 |
| XOMA (XOMA) |
United States |
$0.290B |
122.19 |
| WAVE Life Sciences (WVE) |
Singapore |
$0.288B |
0.00 |
| Puma Biotechnology (PBYI) |
United States |
$0.281B |
0.00 |
| Beyond Air (XAIR) |
United States |
$0.278B |
0.00 |
| Checkpoint Therapeutics (CKPT) |
United States |
$0.278B |
0.00 |
| Cardiff Oncology (CRDF) |
United States |
$0.271B |
0.00 |
| Kaleido Biosciences (KLDO) |
|
$0.248B |
0.00 |
| Frequency Therapeutics (FREQ) |
United States |
$0.247B |
0.00 |
| Kamada (KMDA) |
Israel |
$0.239B |
19.89 |
| AVEO Pharmaceuticals (AVEO) |
United States |
$0.237B |
0.00 |
| Paratek Pharmaceuticals (PRTK) |
United States |
$0.234B |
0.00 |
| Adicet Bio (ACET) |
United States |
$0.229B |
0.00 |
| OVID THERAPEUTC (OVID) |
United States |
$0.229B |
2.01 |
| Adverum Biotechnologies (ADVM) |
United States |
$0.227B |
0.00 |
| Trevena (TRVN) |
United States |
$0.224B |
0.00 |
| Seelos Therapeutics (SEEL) |
United States |
$0.205B |
0.00 |
| Kala Pharmaceuticals (KALA) |
United States |
$0.203B |
0.00 |
| TELA Bio (TELA) |
United States |
$0.197B |
0.00 |
| NextCure (NXTC) |
United States |
$0.193B |
0.00 |
| ObsEva SA (OBSV) |
Switzerland |
$0.192B |
0.00 |
| Talis Biomedical (TLIS) |
United States |
$0.185B |
0.00 |
| OSMOTICA PHARM (OSMT) |
United States |
$0.180B |
0.00 |
| SESEN BIO, INC (SESN) |
United States |
$0.178B |
0.00 |
| CorMedix Inc (CRMD) |
United States |
$0.178B |
0.00 |
| GENFIT S.A (GNFT) |
France |
$0.177B |
0.00 |
| HOOKIPA Pharma (HOOK) |
United States |
$0.176B |
0.00 |
| Enzo Biochem (ENZ) |
United States |
$0.175B |
51.71 |
| ATyr Pharma (LIFE) |
United States |
$0.174B |
0.00 |
| Synlogic (SYBX) |
United States |
$0.172B |
0.00 |
| ADMA Biologics Inc (ADMA) |
United States |
$0.171B |
0.00 |
| Aptinyx (APTX) |
United States |
$0.168B |
0.00 |
| Galena Biopharma (SLS) |
United States |
$0.167B |
0.00 |
| Erytech Pharma SA (ERYP) |
France |
$0.164B |
0.00 |
| Catalyst Biosciences (CBIO) |
United States |
$0.162B |
0.00 |
| POXEL SA FRANCE (PXXLF) |
France |
$0.161B |
0.00 |
| Leap Therapeutics (LPTX) |
United States |
$0.158B |
0.00 |
| F-star Therapeutics (FSTX) |
United Kingdom |
$0.157B |
0.00 |
| Biofrontera AG (BFRA) |
Germany |
$0.156B |
0.00 |
| Dyadic (DYAI) |
United States |
$0.151B |
0.00 |
| LogicBio Therapeutics (LOGC) |
United States |
$0.150B |
0.00 |
| TScan Therapeutics (TCRX) |
United States |
$0.150B |
0.00 |
| VTv Therapeutics (VTVT) |
United States |
$0.148B |
0.00 |
| ANIXA BIOSCIENCES INC (ANIX) |
United States |
$0.147B |
0.00 |
| Applied Genetic Technologies (AGTC) |
United States |
$0.147B |
0.00 |
| Vascular Biogenics (VBLT) |
Israel |
$0.145B |
0.00 |
| Strongbridge Biopharma (SBBP) |
United States |
$0.144B |
0.00 |
| Nicox SA (NICXF) |
France |
$0.142B |
0.00 |
| Novogen (KZIA) |
Australia |
$0.140B |
0.00 |
| Liquidia Technologies (LQDA) |
United States |
$0.140B |
0.00 |
| PHASEBIO PHARMA (PHAS) |
United States |
$0.139B |
0.00 |
| Cyclerion Therapeutics (CYCN) |
United States |
$0.135B |
0.00 |
| X4 Pharmaceuticals (XFOR) |
United States |
$0.131B |
0.00 |
| Evofem Biosciences (EVFM) |
United States |
$0.130B |
0.00 |
| Purple Biotech (PPBT) |
Israel |
$0.128B |
0.00 |
| Eton Pharmaceuticals (ETON) |
United States |
$0.126B |
0.00 |
| Orgenesis (ORGS) |
United States |
$0.125B |
0.00 |
| Exicure (XCUR) |
United States |
$0.124B |
0.00 |
| ASLAN Pharmaceuticals (ASLN) |
Singapore |
$0.122B |
0.00 |
| Abeona Therapeutics (ABEO) |
United States |
$0.121B |
0.00 |
| Voyager Therapeutics (VYGR) |
United States |
$0.118B |
6.76 |
| Eyenovia (EYEN) |
United States |
$0.117B |
0.00 |
| Entera Bio (ENTX) |
Israel |
$0.114B |
0.00 |
| Yumanity Therapeutics (YMTX) |
United States |
$0.114B |
0.00 |
| Viridian Therapeutics (VRDN) |
United States |
$0.112B |
0.00 |
| Cidara Therapeutics (CDTX) |
United States |
$0.105B |
0.00 |
| Cocrystal Pharma (COCP) |
United States |
$0.102B |
0.00 |
| Pluristem Therapeutics (PSTI) |
Israel |
$0.096B |
0.00 |
| Aadi Bioscience (AADI) |
United States |
$0.093B |
0.00 |
| Celsion (CLSN) |
United States |
$0.092B |
0.00 |
| Emmaus Life Sciences (EMMA) |
United States |
$0.085B |
0.00 |
| Aptevo Therapeutics (APVO) |
United States |
$0.084B |
0.00 |
| Zosano Pharma (ZSAN) |
United States |
$0.084B |
0.00 |
| ARAVIVE, INC (ARAV) |
United States |
$0.084B |
0.00 |
| Lumos Pharma (LUMO) |
United States |
$0.084B |
0.00 |
| Adocia (ADOCY) |
France |
$0.083B |
0.00 |
| Statera Biopharma (STAB) |
United States |
$0.082B |
0.00 |
| Stealth BioTherapeutics (MITO) |
Cayman Islands |
$0.081B |
0.00 |
| Liminal BioSciences (LMNL) |
Canada |
$0.081B |
0.00 |
| Aytu BioPharma (AYTU) |
United States |
$0.079B |
0.00 |
| DiaMedica Therapeutics (DMAC) |
United States |
$0.079B |
0.00 |
| Evogene (EVGN) |
Israel |
$0.078B |
0.00 |
| Edesa Biotech (EDSA) |
Canada |
$0.078B |
0.00 |
| Advaxis (ADXS) |
United States |
$0.077B |
0.00 |
| AEterna Zentaris (AEZS) |
United States |
$0.076B |
0.00 |
| TRACON Pharmaceuticals (TCON) |
United States |
$0.074B |
0.00 |
| Vaccinex (VCNX) |
United States |
$0.070B |
0.00 |
| ABVC BioPharma (ABVC) |
United States |
$0.070B |
0.00 |
| AIkido Pharma (AIKI) |
United States |
$0.070B |
0.00 |
| Longeveron (LGVN) |
United States |
$0.069B |
0.00 |
| Vyant Bio (VYNT) |
United States |
$0.069B |
0.00 |
| Celyad SA (CYAD) |
Belgium |
$0.068B |
0.00 |
| Organovo Holdings (ONVO) |
United States |
$0.066B |
0.00 |
| AnPac Bio-Medical Science (ANPC) |
China |
$0.055B |
0.00 |
| Idera Pharmaceuticals (IDRA) |
United States |
$0.054B |
0.00 |
| Enveric Biosciences (ENVB) |
United States |
$0.054B |
0.00 |
| Cyclacel Pharmaceuticals (CYCC) |
United States |
$0.053B |
0.00 |
| Antibe Therapeutics (ATBPF) |
Canada |
$0.053B |
0.00 |
| Acorda Therapeutics (ACOR) |
United States |
$0.053B |
1.10 |
| BioCardia (BCDA) |
United States |
$0.052B |
0.00 |
| Genetic Technologies (GENE) |
Australia |
$0.052B |
0.00 |
| Forte Biosciences (FBRX) |
United States |
$0.051B |
0.00 |
| Windtree Therapeutics (WINT) |
United States |
$0.050B |
0.00 |
| ARIDIS PHARMACT (ARDS) |
United States |
$0.049B |
0.00 |
| Vallon Pharmaceuticals (VLON) |
United States |
$0.048B |
0.00 |
| Pulmatrix (PULM) |
United States |
$0.045B |
0.00 |
| Cyclo Therapeutics (CYTH) |
United States |
$0.044B |
0.00 |
| Soligenix (SNGX) |
United States |
$0.043B |
0.00 |
| Invo BioScience (INVO) |
United States |
$0.037B |
0.00 |
| Palisade Bio (PALI) |
United States |
$0.035B |
0.00 |
| Happiness Biotech Group (HAPP) |
China |
$0.035B |
0.00 |
| Alimera Sciences (ALIM) |
United States |
$0.034B |
0.00 |
| Lexaria Bioscience (LEXX) |
Canada |
$0.032B |
0.00 |
| Benitec Biopharma (BNTC) |
United States |
$0.032B |
0.00 |
| GeoVax Labs (GOVX) |
United States |
$0.030B |
0.00 |
| Prana Biotechnology (ATHE) |
Australia |
$0.029B |
0.00 |
| IMMURON (IMRN) |
Australia |
$0.028B |
0.00 |
| ThermoGenesis Holdings (THMO) |
United States |
$0.027B |
0.00 |
| ZIVO Bioscience (ZIVO) |
United States |
$0.026B |
0.00 |
| Titan Pharmaceuticals (TTNP) |
United States |
$0.020B |
0.00 |
| Sonnet BioTherapeutics Holdings (SONN) |
United States |
$0.016B |
0.00 |
| CollPlant Biotechnologies (CLGN) |
Israel |
$0.000B |
0.00 |
| PDL BioPharma (PDLI) |
United States |
$0.000B |
0.00 |
| UROGEN PHARMA (URGN) |
United States |
$0.000B |
0.00 |
